Therapeutic options for perifolliculitis capitis abscedens et suffodens: A review.

Qingyun Wu, Wenbo Bu, Qian Zhang, Fang Fang

Journal: Dermatologic therapy 2022;35(10):e15763

PMID: 35946169

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Perifolliculitis capitis abscedens et suffodiens (PCAS) is a chronic skin inflammatory disease characterized by relapsing folliculitis and painful, fluctuant abscesses, sinus tracts, and scars. The treatment of PCAS is challenging and clinical practice varies a lot, and how to choose the best treatment for PCAS is a real problem for clinicians. We reviewed articles providing treatment options for patients with PCAS in different databases. Dermatologists may find this review helpful to meet the challenges of PCAS management, but there is still a lack of authoritative guidelines. In the future, more robust randomized control trials are needed to determine the best treatment for PCAS.

Address: Department of Dermatologic Surgery, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu, China.

DOI: 10.1111/dth.15763

Link outs

Free resources

Medical:

https://medlineplus.gov/dandruffcradlecapandothers...

Subscription / membership required

Full Text Sources:

MeSH Terms: Cellulitis, Folliculitis, Humans, Scalp Dermatoses, Skin Diseases, Genetic